Get the Stockscreener App
0.00
100.00%
-40.02
After Hours:
40.00
40.00
+
Pacer Biothreat Strategy Etf stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$40.02
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$40.03
Pacer Biothreat Strategy Etf Stock (VIRS) Company Profile
Name
Pacer Biothreat Strategy Etf
Sector
Industry
Phone
-
Address
-
Compare VIRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIRS
Pacer Biothreat Strategy Etf
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.57 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
601.78 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
604.69 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.55 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
524.47 | 124.43B | 0 | 0 | 0 | 0.00 |
Pacer Biothreat Strategy Etf Stock (VIRS) Latest News
Netflix ETFs to Buy on Robust Q2 Earnings - MSN
Pacer ETFs Celebrates Successful 2024 With Strong Asset Growth, Innovative Fund Launches and Industry Accolades - Business Wire
Pacer ETFs Introduces Two New Products to Fund Lineup with Launch of Pacer US Cash Cows Bond ETF and Pacer Solactive Whitney Future of Warfare ETF - Business Wire
Pacer ETFs Recognized as Best US Equity ETF Issuer ($10bn-$100bn) at the 2024 ETF Express US Awards - Business Wire
(VIRS) Investment Report - Stock Traders Daily
Disruptive Theme of the Week: Top ETF Themes Through Q3 2024 - ETFdb.com
Ziraat Portfoy Yonetimi A.SExchange Traded Fund (etf) (Z30KP.IS) Latest Stock News & Headlines - Yahoo Finance
Pacer Advisors, Inc. to Close and Liquidate the Pacer BioThreat Strategy ETF (VIRS) and the Pacer CSOP FTSE China A50 ETF (AFTY) - Business Wire
Aeffe sells 'Moschino' brand for perfumes to Euroitalia - Yahoo Finance UK
(VIRS) Proactive Strategies - Stock Traders Daily
Russia's central bank does not rule out another rate hike in October - Yahoo Finance UK
Premier League partner Sorare to appear in court on gambling licence charges - Yahoo Finance UK
German economy to shrink again in 2024: think tanks - Yahoo Finance UK
Google restricts creation of new accounts in Russia, news agencies report - Yahoo Finance UK
Thyssenkrupp names Henne as steel unit's new supervisory board head - Yahoo Finance UK
Sterling rises versus dollar and euro on strong risk appetite - Yahoo Finance UK
Pacer ETFs Introduces New Way to Access World’s Most Innovative Companies with Launch of the Pacer Nasdaq International Patent Leaders ETF - Business Wire
(VIRS) Technical Pivots with Risk Controls - Stock Traders Daily
International Assets Investment Management LLC Trims Stock Position in Pacer BioThreat Strategy ETF (BATS:VIRS) - Defense World
James H. Mackaness Sells 6,661 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock - Defense World
Investing in Nobel Prize Achievements – Hepatitis Virus Discovery - Securities.io
WMT Surge: 10 ETFs with largest Walmart holdings as retailer’s stock jumps to record high - Seeking Alpha
(VIRS) Technical Data - Stock Traders Daily
Netflix ETFs in Focus Ahead of Q2 Earnings - Nasdaq
Watch Pacer ETFs President on US Small Cap ETF (CALF) - Bloomberg
Netflix ETFs to Buy on the Dip Post Solid Q1 Earnings - Yahoo Finance
What Lies in Store for Netflix ETF in Q1 Earnings? - Yahoo Finance
The 10 Best Healthcare & Biotech ETFs to Buy Now - TheStreet
3 Best Biotech ETFs By Market Performance - Seeking Alpha
ETFs Most Exposed To Netflix’s Epic Sell-Off - Yahoo Finance
GBP/USD Daily Forecast – U.S. Dollar Pulls Back After Yesterday’s Rally - Yahoo Finance
How to Invest in the Future of Vaccines - Bloomberg
Seven ETFs for (financial) health - Master Investor
5 Sector ETFs At All-Time Highs - Yahoo Finance
COVID Biotech ETFs Rise At Fever Pace - Yahoo Finance
5 ETFs to Make the Most of Thermo Fisher Deal to Buy PPD - Yahoo Finance
ETFs to Watch Ahead of Nvidia's Q3 Earnings - Zacks Investment Research
Beating COVID-19 With The Pacer BioThreat Strategy ETF (Podcast Transcript) (NYSEARCA:ALTL) - Seeking Alpha
Beating COVID-19 With The Pacer BioThreat Strategy ETF (Podcast) (NYSEARCA:ALTL) - Seeking Alpha
3 ETFs For Nvidia's Big Arm Holdings Acquisition - Yahoo Finance
New virus-themed ETF trades under ticker GERM - InvestmentNews
Draco Evolution AI ETF (DRAI) Latest Stock News & Headlines - Yahoo Finance
Pacer Biothreat Strategy Etf Stock (VIRS) Financials Data
There is no financial data for Pacer Biothreat Strategy Etf (VIRS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.00%
Cap:
|
Volume (24h):